The bridge is already built: management walks investors from today's numbers to a bigger business using only pieces alre
The model's full reasoning — Q1 2018 call → NOWe need answer only YES or NO. Need evaluate based on transcript. Need determine if management explains forward business over next year primarily out of specific pieces already secured/in motion, such that results understate locked-in business. Let's parse transcript. Management discusses Q1 2018 results, guidance raised. Forward-looking elements: sequencing consumables growth, NovaSeq rollout multiyear, iSeq beta and scale shipments midyear, oncology collaborations with Loxo and BMS (milestone payments included in guidance, but no revenue in Q1, future milestones), microarray growth due to consumer genomics, Helix, etc. Need see if they present path from today's numbers to meaningfully larger near-term business as walk across pieces that already exist. Specific pieces: - NovaSeq upgrade cycle: multiyear, customers transitioning, but not fully secured? They have orders and shipments, 330-350 NovaSeq shipments expected. But that's guidance, not necessarily locked-in? They mention order and shipment volumes consistent. - iSeq: beta testing, improvements, expect scale shipments midyear, approaching 100 orders. This is a product launch, scheduled to ramp. Is it material? Probably small. - Oncology collaborations with Loxo and BMS: signed partnerships, companion diagnostics, milestones included in guidance, but no revenue in Q1. These are secured agreements, but contributions are milestone-based, may be contingent on development/approval? They are "milestone payments associated with recently announced oncology collaborations" included in guidance. But are they near-term and material? They mention multiyear collaborations, milestones over next couple years. Not necessarily next year? They included in 2018 guidance, so some revenue this year. But is it material? They don't size. - Microarray business: strong growth, consumer genomics inflection, but forward story relies on market growth and demand, not locked-in contracts? They mention WeGene using platform, but that's a customer relationship, not necessarily committed volumes. - Harvard Pilgrim NIPT study, MiSeq study: investments to support adoption, not revenue. - Population genomics: Genomics England halfway through 100k, hopes to complete this year, then clinical WGS. UK Biobank sequencing 50k over next two years, funded, conducted by Sanger using Illumina technology.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| DUOT | Duos Technologies Group, Inc. | Q4 2023 | 2024-04-01 | F |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| OEC | Orion Engineered Carbons S.A. | Q4 2022 | 2023-02-17 | B+ |
| ESEA | Euroseas Ltd. | Q4 2022 | 2023-02-15 | C+ |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| PKOH | Park-Ohio Holdings Corp. | Q3 2022 | 2022-11-13 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| VNRX | VolitionRx Limited | Q1 2022 | 2022-05-12 | F |
| ZVIA | Zevia PBC | Q1 2022 | 2022-05-12 | B |
| BXP | Boston Properties, Inc. | Q1 2022 | 2022-05-03 | A |
| ADSE | ADS-TEC Energy PLC | Q4 2021 | 2022-04-28 | D |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| EGY | VAALCO Energy, Inc. | Q2 2021 | 2021-08-12 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| WES | Western Midstream Partners, LP | Q3 2018 | 2018-10-31 | D |
| KOP | Koppers Holdings Inc. | Q2 2018 | 2018-08-12 | C+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| XOM | Exxon Mobil Corporation | Q2 2018 | 2018-07-27 | C |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| UPLD | Upland Software, Inc. | Q4 2017 | 2018-03-08 | C+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| CPK | Chesapeake Utilities Corporation | Q3 2017 | 2017-11-10 | A |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| LBTYK | Liberty Global's | Q1 2016 | 2016-05-10 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
| ACCO | ACCO Brands Corporation | Q1 2016 | 2016-04-27 | B+ |
EVGO · Q2 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, making current results understate the locked-in...YES The transcript shows management framing the next-year outlook around the newly announced, signed GM-Pilot eXtend deal (up to 2,000 stalls at 500 locations, with EVgo procuring, constructing, operating, and maintaining, delivering both near-term revenue and longer-term contracted cash flows that already exceed IRR hurdles) plus the Delta supply agreement (1,000+ chargers for 2,000 stalls through 2026) and the GSA BPA (which removes procurement friction for federal fleets). These pieces are presented as already committed and in motion, with explicit timing for revenue ramp in H2 2022 and into 202 3, while the company notes it has baked some of the PFJ contribution into its 2022 guidance. The structure treats these secured elements as the primary bridge from today’s numbers to a meaningfully larger business, rather than relying on pipeline, demand, or future bids. Other items (NEVI solicitations, fleet pilots ) are secondary and contingent, but the core forward posture is built on the named, already-executed contracts and programs. Current results visibly understate the locked-in trajectory because the eXtend model shifts cash flows forward and the secured stalls/contracts are only beginning to flow.
BRBR · Q4 2023 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing fiscal '24 growth as driven by concrete, already-committed pieces: the two co-man additions from '23 that are scaling, the Michael Foods greenfield facility that starts up in December and will be a "much larger contributor" in the second half of '24, the 20 %+ production growth plan (40 % from new co-mans in '24, 40 % from lapping prior adds, 20 % from existing), and the restart of shake promotions in Q2 plus marketing step-up in Q4 once target weeks of supply are reached. These are presented as nameable, scheduled 2024 actions that will enable double-digit volume growth for both Premier Protein and Dymatize, with the current-year results (22 % sales growth under capacity constraints) treated as a base that the locked-in capacity ramp will visibly outgrow.
MEC · Q3 2022 → YESThe question is about whether management's explanation of the next year's business is built primarily from specific pieces already secured or in motion, such that current results understate the locked...YES The transcript shows management framing 2023 growth primarily around specific, already secured or in-motion pieces: the electric side-by-side family of parts (production fully launching in 2023), the reshoring project for the commercial vehicle customer (production scheduled to start early 2023), the high-value ag takeover project (already awarded), incremental business on the light-duty truck platform, and the new industrial infrastructure customer relationship (quickly supported and expected to grow). These are presented as nameable, committed items whose contributions are beginning or ramping over the coming year.